Products
MeMed BV
COVID-19 Severity
MeMed Key
Pipeline
Learning Center
Publications
Podcasts
Presentations & Abstracts
Videos
Webinars
About Us
Our Team
Core Values
Careers
News
Press Releases
Events
Customer Support
Contact Us
Search
US
Global
Request a Demo
News
Maccabi Healthcare Services Announces it is the First HMO in the World to Include MeMed BV® Test as Part of Routine Care
07 Jun 2022
DiaSorin receives FDA 510(K) clearance for Its LIAISON MeMed BV test
25 Jul 2022
MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio
10 Jan 2022
Maimonides Medical Center adopts revolutionary technology that quickly distinguishes bacterial and viral Infections
22 Mar 2022
After a decade and 130 million dollars, the MeMed test receives FDA clearance
27 Oct 2021
2021 Dun & Bradstreet’s Best Companies to Work For
31 Dec 2021
Platform distinguishing between viral and bacterial infections cleared by FDA
28 Sep 2021
FDA Clears New Technology to Differentiate Bacterial, Viral Infections Using Biomarkers
28 Sep 2021
Bacterial and Viral Biomarker Test Gains US FDA Clearance
27 Sep 2021
MeMed Gets FDA 510(k) Clearance for Test Distinguishing Between Viral, Bacterial Infections
27 Sep 2021
Israel’s MeMed gets FDA approval for ‘breakthrough’ infection test
26 Sep 2021
MeMed Received FDA Clearance for Infection Test
26 Sep 2021
FDA clears MeMed’s point-of-need infectious disease test
26 Sep 2021
US approves MeMed test to distinguish bacterial from viral infections
26 Sep 2021
MeMed’s Diagnostics, BV Test and Key Platform Get 510(k) Clearance
26 Sep 2021
Rapid test to distinguish bacterial and viral infections wins US approval
20 Sep 2021
Pioneering test which can indicate COVID-19 severity receives CE Mark
12 Sep 2021
COVID-19 severity test is approved for sale in the UK
11 Sep 2021
Longitude Prize: Bacterial or Viral: To Treat or Not to Treat with Antibiotics
04 Sep 2017
Test predicting COVID-19 severity receives CE mark
27 Jul 2021
MeMed’s Covid-19 severity test receives its CE Mark to predict severe outcomes
27 Jul 2021
MeMed Wins $4.1M DOD Grant toward Manufacturing of POC Platform
16 Feb 2018
MeMed Receives CE Mark for Diagnostic Platform & Infection Assay
04 Jun 2021
MeMed’s co-founder and CEO, Dr. Eran Eden on the BioBoss Podcast
25 Sep 2020
Israeli firm advances diagnostic solutions for Covid-19
07 Jul 2020
Interview with Eran Eden, MeMed’s CEO
27 Mar 2020
Israeli Startups Join The Fight Against Coronavirus
18 Mar 2020
OurCrowd Portfolio Companies Pivot to Tackle Coronavirus Pandemic
07 Mar 2020
Technology Pioneers 2019
27 Apr 2019
Rapid blood test to ‘cut antibiotic use’
27 Mar 2015
A New Blood Test Could Stop Doctors From Overprescribing Antibiotics
17 Sep 2013
Contact Us
7 Nahum Het St., Tirat Carmel
Park High-Tech North, 3508506, Israel
+972-4-8500302
200 Brickstone Sq., Ste.106
Andover, MA 01801, USA
+1-888-203-4550
Linkedin
Facebook
Twitter